5 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Unknown 5 |
Follow raltitrexed: new trials by email Literature Review of raltitrexed trials Research Report on raltitrexed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial Oxaliplatin, Doxorubicin, Lobaplatin - Hepatocellular Carcinoma Resectable | Phase 3 | Unknown | Zhujiang Hospital | 90 | 2023-01-01 | 2023-03-13 |
| Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial Oxaliplatin, Doxorubicin, Lobaplatin - Liver, Cancer of, Primary Resectable | Phase 3 | Unknown | Zhujiang Hospital | 144 | 2022-09-01 | 2023-03-02 |
| Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 426 | 2022-03-28 | 2022-05-24 |
| Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer Raltitrexed, 5-fluorouracil, Cisplatin - Head and Neck Squamous Cell Cancer | Phase 3 | Unknown | Jiangsu Cancer Institute & Hospital | 120 | 2015-06-01 | 2015-06-30 |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer fluorouracil, leucovorin calcium, raltitrexed - Colorectal Cancer | Phase 3 | Unknown | Medical Research Council | 900 | 1995-06-01 | 2013-12-19 |
Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Rectal Neoplasms (1)
Zhujiang Hospital (2) · Jiangsu Cancer Institute & Hospital (1) · Medical Research Council (1) · Sun Yat-sen University (1)
China (4) · United Kingdom (1)
Ming Zhao, M.D. & Ph.D. (1) · Mingxin Pan, Prof (1) · Mingxin Pan, Prof. (1) · Timothy Maughan, MD (1) · Xia He, M.D. (1)